Curative chemoradiation for low rectal cancer: Primary clinical outcomes from a multicenter phase II trial.

被引：0
|
作者：
Jensen, Lars Henrik
Risum, Signe
Nielsen, Jesper Dan
Mynster, Tommie
Ploeen, John
Rahr, Hans B.
Havelund, Birgitte Mayland
Appelt, Ane L.
Lindebjerg, Jan
Rafaelsen, Soeren Rafael
Jakobsen, Anders
Poulsen, Laurids
机构：
[1] Vejle Univ Hosp, Danish Colorectal Canc Ctr South, Vejle, Denmark
[2] Rigshosp, Dept Oncol, Copenhagen, Denmark
[3] Aalborg Univ Hosp, Dept Surg, Aalborg, Denmark
[4] Bispebjerg Hosp, Dept Surg, Copenhagen, Denmark
[5] Univ Hosp Copenhagen, Copenhagen, Denmark
[6] Vejle Hosp, Danish Colorectal Canc Grp South, Vejle, Denmark
[7] Vejle Hosp, Danish Colorectal Canc Ctr South, Vejle, Denmark
[8] Univ Hosp Southern Denmark, Vejle Hosp, Dept Oncol, Vejle, Denmark
[9] Aalborg Univ Hosp, Dept Oncol, Aalborg, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA3514
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial
    Wong, C. S.
    Chu, W.
    Ashamalla, S.
    Fenech, D.
    Berry, S.
    Kiss, A.
    Koritzinsky, M.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 30 : 60 - 64
  • [32] A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial
    Jakobsen, Anders
    Mortensen, John Ploen
    Bisgaard, Claus
    Lindebjerg, Jan
    Rafaelsen, Soren Rafael
    Bendtsen, Vagn Ove
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (03) : 251 - 255
  • [33] Trifluridine/Tipiracil Based Chemoradiation in locally Advanced Rectal Cancer: The Phase I/II TARC Trial
    Thiele, Benjamin
    Stein, Alexander
    Schultheiss, Christoph
    Paschold, Lisa
    Jonas, Hanna
    Goekkurt, Eray
    Ruessel, Joern
    Schuch, Gunter
    Wierecky, Jan
    Sinn, Marianne
    Tintelnot, Joseph
    Petersen, Cordula
    Rothkamm, Kai
    Vettorazzi, Eik
    Binder, Mascha
    CLINICAL COLORECTAL CANCER, 2025, 24 (01) : 11 - 17
  • [34] A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial
    Anders Jakobsen
    John Pløen Mortensen
    Claus Bisgaard
    Jan Lindebjerg
    Søren Rafael Rafaelsen
    Vagn Ove Bendtsen
    International Journal of Colorectal Disease, 2008, 23 : 251 - 255
  • [35] Short-term outcomes of laparoscopy-assisted versus open surgery for low rectal cancer (LASRE): A multicenter, randomized, controlled trial.
    Chi, Pan
    Su, Xiangqian
    Xu, Jianmin
    Qiu, Huizhong
    Wang, Ziqiang
    Kang, Liang
    Deng, Haijun
    Chen, Weiping
    Zhang, Qingtong
    Du, Xiaohui
    Yang, Chunkang
    Guo, Yincong
    Zhong, Ming
    Ye, Kai
    You, Jun
    Xu, Dongbo
    Li, Xinxiang
    Xiong, Zhiguo
    Tao, Kaixiong
    Ding, Ke-Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] The role of concomitant boost in chemoradiation for rectal cancer; a randomized clinical trial
    Aghili, Mahdi
    Nourbakhsh, Forouzan
    Babaei, Mohammad
    Lashkari, Marzieh
    Ghalehtaki, Reza
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1523 - S1524
  • [37] Preoperative Treatment with Capecitabine, Cetuximab and Radiotherapy for Primary Locally Advanced Rectal Cancer - A Phase II Clinical Trial
    Eisterer, Wolfgang
    De Vries, Alexander
    Oefner, Dietmar
    Rabl, Hans
    Koplmueller, Renate
    Greil, Richard
    Tschmelitsch, Joeerg
    Schmid, Rainer
    Kapp, Karin
    Lukas, Peter
    Sedlmayer, Felix
    Hoefler, Gerald
    Gnant, Michael
    Thaler, Josef
    ANTICANCER RESEARCH, 2014, 34 (11) : 6767 - 6773
  • [38] Transscleral Iontophoresis of cortcicosteoids: Phase II clinical trial.
    Chauvaud, D
    Behar-Cohen, FF
    Parel, JM
    Renard, G
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S79 - S79
  • [39] Bevacizumab with chemoradiation in rectal cancer: clinical and translational results of the AXEBeam trial
    Verstraete, M.
    Debucquoy, A.
    Dekervel, J.
    Van Pelt, J.
    Chiritescu, G.
    Dumon, K.
    D'Hoore, A.
    Sagaert, X.
    Van Cutsem, E.
    Haustermans, K.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S97 - S97
  • [40] Multicenter phase II trial of neoadjuvant chemotherapy with mFOLFOX6 for stage II/III rectal cancer with a T3/T4 tumor FACT trial.
    Enomoto, Toshiyuki
    Saida, Yoshihisa
    Takabayashi, Kazuhiro
    Nagao, Jiro
    Koike, Junichi
    Funahashi, Kimihiko
    Yoshimatsu, Kazuhiko
    Yokomizo, Hajime
    Kan, Hayato
    Yamada, Takeshi
    Ishida, Hideyuki
    Ishibashi, Keiichiro
    Katsumata, Kenji
    Hasegawa, Hirotoshi
    Koda, Keiji
    Ochiai, Takumi
    Sakamoto, Kazuhiro
    Ogawa, Shimpei
    Itabashi, Michio
    Kameoka, Shingo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345